JP2018512161A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018512161A5 JP2018512161A5 JP2017554035A JP2017554035A JP2018512161A5 JP 2018512161 A5 JP2018512161 A5 JP 2018512161A5 JP 2017554035 A JP2017554035 A JP 2017554035A JP 2017554035 A JP2017554035 A JP 2017554035A JP 2018512161 A5 JP2018512161 A5 JP 2018512161A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- cell
- modified
- receptor
- antigen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021203173A JP2022046549A (ja) | 2015-04-15 | 2021-12-15 | 修正ガンマデルタｔ細胞およびその使用 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1506423.1A GB201506423D0 (en) | 2015-04-15 | 2015-04-15 | Gamma delta T cells and uses thereof |
| GB1506423.1 | 2015-04-15 | ||
| GBPCT/GB2015/051985 | 2015-07-08 | ||
| PCT/GB2015/051985 WO2016005752A1 (en) | 2014-07-09 | 2015-07-08 | Gamma delta t cells and uses thereof |
| PCT/GB2016/051050 WO2016166544A1 (en) | 2015-04-15 | 2016-04-14 | Modified gamma delta cells and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021203173A Division JP2022046549A (ja) | 2015-04-15 | 2021-12-15 | 修正ガンマデルタｔ細胞およびその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018512161A JP2018512161A (ja) | 2018-05-17 |
| JP2018512161A5 true JP2018512161A5 (https=) | 2019-05-23 |
| JP6995624B2 JP6995624B2 (ja) | 2022-02-21 |
Family
ID=53333850
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017554035A Active JP6995624B2 (ja) | 2015-04-15 | 2016-04-14 | 修正ガンマデルタｔ細胞およびその使用 |
| JP2021203173A Ceased JP2022046549A (ja) | 2015-04-15 | 2021-12-15 | 修正ガンマデルタｔ細胞およびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021203173A Ceased JP2022046549A (ja) | 2015-04-15 | 2021-12-15 | 修正ガンマデルタｔ細胞およびその使用 |
Country Status (15)
| Country | Link |
|---|---|
| US (2) | US10881688B2 (https=) |
| EP (1) | EP3283620B1 (https=) |
| JP (2) | JP6995624B2 (https=) |
| KR (1) | KR20180012754A (https=) |
| CN (2) | CN107810267B (https=) |
| AU (2) | AU2016250211B2 (https=) |
| BR (1) | BR112017022249A2 (https=) |
| CA (1) | CA2982523A1 (https=) |
| EA (1) | EA201792041A1 (https=) |
| ES (1) | ES2993441T3 (https=) |
| GB (1) | GB201506423D0 (https=) |
| IL (1) | IL255011B (https=) |
| SG (1) | SG11201708401WA (https=) |
| WO (1) | WO2016166544A1 (https=) |
| ZA (1) | ZA201706922B (https=) |
Families Citing this family (62)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201506423D0 (en) | 2015-04-15 | 2015-05-27 | Tc Biopharm Ltd | Gamma delta T cells and uses thereof |
| GB201507368D0 (en) | 2015-04-30 | 2015-06-17 | Ucl Business Plc | Cell |
| ES2965437T3 (es) | 2015-09-03 | 2024-04-15 | Uab Res Found | Células T modificadas genéticamente resistentes a fármacos y procedimientos de utilización de las mismas |
| EP3516043A1 (en) * | 2016-09-26 | 2019-07-31 | Tessa Therapeutics Pte. Ltd. | T cell expansion method |
| US11421005B2 (en) | 2016-12-09 | 2022-08-23 | The Uab Research Foundation | Chimeric chlorotoxin receptors |
| GB201701332D0 (en) | 2017-01-26 | 2017-03-15 | Tc Biopharm Ltd | Immune cells with modified metabolism and their use thereof |
| SG10202107136XA (en) * | 2017-02-08 | 2021-07-29 | Agency Science Tech & Res | Gamma delta t cells and a method of augmenting the tumoricidal activity of the same |
| GB201707048D0 (en) | 2017-05-03 | 2017-06-14 | King S College London | Expansion of gamma delta cells, compositions, and methods of use thereof |
| EP3624823A1 (en) * | 2017-05-18 | 2020-03-25 | UMC Utrecht Holding B.V. | Compositions and methods for cell targeting therapies |
| SG11202000606TA (en) * | 2017-07-29 | 2020-02-27 | Juno Therapeutics Inc | Reagents for expanding cells expressing recombinant receptors |
| GB201715918D0 (en) | 2017-09-29 | 2017-11-15 | Tc Biopharm Ltd | Modified CAR-T |
| TWI687227B (zh) * | 2017-10-03 | 2020-03-11 | 生倍科技股份有限公司 | 用於t細胞免疫療法之組合及其用途 |
| CN109777778B (zh) * | 2017-11-14 | 2023-07-18 | 中国科学院广州生物医药与健康研究院 | 一种基因改造的γδT细胞 |
| DE102017127984B4 (de) | 2017-11-27 | 2019-12-05 | Immatics US, Inc. | Verfahren für die Vermehrung und Aktivierung von γδ-T-Zellen |
| CN108085341A (zh) * | 2017-12-28 | 2018-05-29 | 河南省华隆生物技术有限公司 | 一种msgv重组载体及其制备方法和应用 |
| GB201804701D0 (en) * | 2018-03-23 | 2018-05-09 | Gammadelta Therapeutics Ltd | Lymphocytes expressing heterologous targeting constructs |
| CN108588023B (zh) * | 2018-05-09 | 2020-02-14 | 河北森朗生物科技有限公司 | 一种生产嵌合抗原受体修饰的γδT细胞的方法 |
| CN110577932A (zh) * | 2018-06-07 | 2019-12-17 | 亘喜生物科技（上海）有限公司 | 一种脐带血来源的嵌合抗原受体t细胞 |
| CN109234236A (zh) * | 2018-09-29 | 2019-01-18 | 吉林大学第医院 | 一种嵌合抗原受体γδT细胞的制备方法 |
| US20210388100A1 (en) * | 2018-10-01 | 2021-12-16 | Adicet Bio, Inc. | Compositions and methods regarding engineered and non-engineered gamma delta t-cells for treatment of hematological tumors |
| SG11202103234RA (en) * | 2018-10-01 | 2021-04-29 | Adicet Bio Inc | COMPOSITIONS AND METHODS REGARDING ENGINEERED AND NON-ENGINEERED γδ -T CELLS FOR TREATMENT OF SOLID TUMORS |
| AU2019376632B2 (en) * | 2018-11-05 | 2025-07-24 | Xyphos Biosciences Inc. | Non-natural NKG2D receptors that do not directly signal the cells to which they are attached |
| CA3120563A1 (en) | 2018-11-26 | 2020-06-04 | Nkarta, Inc. | Methods for the simultaneous expansion of multiple immune cell types, related compositions and uses of same in cancer immunotherapy |
| CN109517793B (zh) * | 2018-11-30 | 2022-05-10 | 广州长峰生物技术有限公司 | 一种NK细胞和γδT细胞共培养的建立方法 |
| EP4219688B1 (en) * | 2018-12-19 | 2026-01-28 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Mucosal-associated invariant t (mait) cells expressing chimeric antigen receptors |
| CN109762843A (zh) * | 2018-12-29 | 2019-05-17 | 武汉波睿达生物科技有限公司 | 一种利用脐血来源的cd3阳性t细胞制备通用car-t细胞的方法 |
| CN109609465A (zh) * | 2018-12-29 | 2019-04-12 | 武汉波睿达生物科技有限公司 | 一种利用脐血来源的γδT细胞制备CAR-T细胞的方法及该CAR-T细胞和应用 |
| EP3773918A4 (en) | 2019-03-05 | 2022-01-05 | Nkarta, Inc. | CD19 DIRECTED CHIMERIC ANTIGEN RECEPTORS AND THEIR USES IN IMMUNOTHERAPY |
| WO2020216238A1 (en) * | 2019-04-22 | 2020-10-29 | Nanjing Legend Biotech Co., Ltd. | Engineered cells and uses thereof |
| US12480958B2 (en) | 2019-08-13 | 2025-11-25 | Immatics Biotechnologies Gmbh | Method for the characterization of peptide:MHC binding polypeptides |
| JP7764364B2 (ja) * | 2019-08-16 | 2025-11-05 | ガンマデルタ セラピューティクス リミティッド | エクスビボγδ Ｔ細胞集団 |
| JP2022545196A (ja) * | 2019-08-16 | 2022-10-26 | ガンマデルタ セラピューティクス リミテッド | 抗ｔｃｒデルタ可変１抗体の治療的使用 |
| CN110964698B (zh) * | 2019-12-25 | 2022-05-10 | 杭州中赢生物医疗科技有限公司 | 一种人工抗原递呈细胞及其制备方法和应用 |
| US20230226183A1 (en) * | 2020-01-15 | 2023-07-20 | The Regents Of The University Of California | Compositions and methods for altering gamma delta t cell activity |
| CA3168729A1 (en) * | 2020-02-24 | 2021-09-02 | Melinda MATA | Methods for expanding t cells for the treatment of cancer and related malignancies |
| CN115485369A (zh) * | 2020-03-03 | 2022-12-16 | 詹森生物科技公司 | γδT细胞及其用途 |
| KR20230013022A (ko) * | 2020-03-20 | 2023-01-26 | 감마델타 테라퓨틱스 엘티디 | 골수성 악성종양의 치료를 위한 v 델타1+ t 세포 |
| US20230203125A1 (en) | 2020-05-22 | 2023-06-29 | Chongqing Precision Biotech Co., Ltd. | Fusion protein for reversing tumor microenvironment and use thereof |
| US20230226181A1 (en) * | 2020-06-22 | 2023-07-20 | Nanjing Legend Biotech Co., Ltd. | GENETIC ENGINEERING OF gamma delta T CELLS FOR IMMUNOTHERAPY |
| EP4182338A1 (en) | 2020-07-17 | 2023-05-24 | Instil Bio (Uk) Limited | Receptors providing targeted costimulation for adoptive cell therapy |
| PL4269444T3 (pl) * | 2020-08-14 | 2025-01-13 | GammaDelta Therapeutics Limited | Wieloswoiste przeciwciała anty-tcr zmienne delta 1 |
| CN114591907A (zh) * | 2020-12-03 | 2022-06-07 | 复旦大学 | 一种γδT细胞的制备和扩增方法以及应用 |
| CN112481284B (zh) * | 2020-12-07 | 2023-07-25 | 深圳瑞吉生物科技有限公司 | 一种编码CAR基因的mRNA、组合mRNA、构建方法、CAR-T细胞和应用 |
| CN114685684A (zh) * | 2020-12-31 | 2022-07-01 | 博生吉医药科技(苏州)有限公司 | MUC1-Tn嵌合抗原受体修饰的Vγ9Vδ2T细胞及其应用 |
| MX2023009544A (es) | 2021-02-17 | 2023-11-28 | Gammadelta Therapeutics Ltd | Anticuerpos anti-variable delta 1 de tcr multiespecíficos. |
| AU2022224391A1 (en) * | 2021-02-17 | 2023-08-24 | Gammadelta Therapeutics Ltd | Anti-tcr delta variable 1 antibodies |
| AU2022253611B2 (en) * | 2021-04-06 | 2026-04-09 | Unicet Biotech Co. Llc | METHODS TO IMPROVE STABILITY OF VIRUS TRANSDUCTION OF γδ T CELLS AND APPLICATIONS THEREOF |
| WO2022221506A1 (en) * | 2021-04-16 | 2022-10-20 | Acepodia Biotechnologies Ltd. | Novel compositions enriched in gamma delta t cells, methods of preparation, and uses thereof |
| CN113156142B (zh) * | 2021-04-16 | 2024-09-27 | 苏州才博医学科技有限公司 | 一种针对异体cart细胞特异性抗体的检测方法 |
| GB202105686D0 (en) * | 2021-04-21 | 2021-06-02 | Imperial College Innovations Ltd | Chimeric antigen receptor (CAR)-T cells |
| GB202105684D0 (en) * | 2021-04-21 | 2021-06-02 | Imperial College Innovations Ltd | Chimeric antigen receptor (CAR)-T cells |
| US20240245772A1 (en) * | 2021-05-19 | 2024-07-25 | Celledit Llc | Bi-specific chimeric antigen receptors and genetically engineered immune cells expressing such |
| WO2022266192A1 (en) | 2021-06-16 | 2022-12-22 | Instil Bio, Inc. | Receptors providing targeted costimulation for adoptive cell therapy |
| EP4370213A4 (en) | 2021-07-16 | 2025-06-04 | Instil Bio (Uk) Limited | Chimeric molecules for targeted costimulation for adoptive cell therapy |
| CN113667640B (zh) * | 2021-08-27 | 2022-09-02 | 广州百暨基因科技有限公司 | CAR-γδT细胞的制备方法 |
| WO2023069322A1 (en) * | 2021-10-20 | 2023-04-27 | University Of Pittsburgh – Of The Commonwealth System Of Higher Education | Methods and materials for expanding tumor infiltrating gamma-delta t cells |
| KR20240149401A (ko) | 2022-02-16 | 2024-10-14 | 프리오테라 에스에이에스 | S1p 수용체 조정제와 조합된 car 세포를 이용한 치료 방법 |
| CN114645022B (zh) * | 2022-05-13 | 2022-09-02 | 首都医科大学宣武医院 | 靶向CD5的CAR-γ δ T细胞及其制备方法与应用 |
| EP4531876A4 (en) * | 2022-06-01 | 2026-03-25 | Sens Res Foundation | TARGETED ELIMINATION OF SENESCENT CELLS BY GAMMA-DELTA T LYMPHOCYTES |
| CN116813794B (zh) * | 2023-02-27 | 2024-07-12 | 武汉波睿达生物科技有限公司 | 共表达spi1的嵌合抗原受体及其应用 |
| EP4458412A1 (en) | 2023-05-05 | 2024-11-06 | University College Cardiff Consultants, Ltd. | Novel phosphoantigen prodrug compound and use thereof |
| CN120554516B (zh) * | 2025-07-30 | 2025-10-24 | 杭州华大生命科学研究院 | 抗cd45抗体及其应用 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1147186A4 (en) | 1999-01-28 | 2002-05-15 | Palmetto Health Alliance D B A | In vitro activated gamma delta lymphocytes |
| ES2336302T3 (es) | 2000-04-03 | 2010-04-12 | Therapure Biopharma Inc. | Produccion de celulas ttcr gamma delta. |
| DE60115069T2 (de) | 2000-09-11 | 2006-08-03 | Chiron Corp., Emeryville | Chinolinonderivate als tyrosin-kinase inhibitoren |
| WO2006006720A1 (ja) | 2004-07-13 | 2006-01-19 | Medinet., Co.Ltd | γδＴ細胞の培養方法、γδＴ細胞及び治療・予防剤 |
| DE602005022728D1 (de) | 2004-08-19 | 2010-09-16 | Univ Cardiff | Präparation antigenpräsentierender menschlicher gamma delta t-zellen und verwendung in der immuntherapie |
| EP1930414B1 (en) | 2005-09-08 | 2012-07-18 | Medinet Co., Ltd. | Method for activation treatment of antigen-presenting cell |
| JPWO2008152822A1 (ja) | 2007-06-15 | 2010-08-26 | 株式会社メディネット | 医薬 |
| PH12013501201A1 (en) * | 2010-12-09 | 2013-07-29 | Univ Pennsylvania | Use of chimeric antigen receptor-modified t cells to treat cancer |
| CA2861491C (en) | 2012-02-13 | 2020-08-25 | Seattle Children's Hospital D/B/A Seattle Children's Research Institute | Bispecific chimeric antigen receptors and therapeutic uses thereof |
| WO2014055657A1 (en) * | 2012-10-05 | 2014-04-10 | The Trustees Of The University Of Pennsylvania | Use of a trans-signaling approach in chimeric antigen receptors |
| CN113005091A (zh) | 2013-02-06 | 2021-06-22 | 细胞基因公司 | 具有改进特异性的修饰的t淋巴细胞 |
| EP3783098A1 (en) | 2013-05-14 | 2021-02-24 | Board Of Regents, The University Of Texas System | Human application of engineered chimeric antigen receptor (car) t-cells |
| EP3925618A1 (en) | 2013-07-29 | 2021-12-22 | 2seventy bio, Inc. | Multipartite signaling proteins and uses thereof |
| EP3060059A4 (en) | 2013-10-25 | 2017-11-01 | Board of Regents, The University of Texas System | Polyclonal gamma delta t cells for immunotherapy |
| WO2015066262A1 (en) | 2013-11-04 | 2015-05-07 | Trustees Of Dartmouth College | Methods for preventing toxicity of adoptive cell therapy |
| MX373687B (es) | 2013-11-21 | 2020-07-07 | Ucl Business Ltd | Célula natural (nk) |
| KR102375998B1 (ko) | 2014-02-14 | 2022-03-21 | 더 보드 오브 리젠츠 오브 더 유니버시티 오브 텍사스 시스템 | 키메라 항원 수용체 및 제조방법 |
| US20170335281A1 (en) * | 2014-03-15 | 2017-11-23 | Novartis Ag | Treatment of cancer using chimeric antigen receptor |
| CA2945388A1 (en) | 2014-04-23 | 2015-10-29 | Board Of Regents, The University Of Texas System | Chimeric antigen receptors (car) for use in therapy and methods for making the same |
| GB201506423D0 (en) | 2015-04-15 | 2015-05-27 | Tc Biopharm Ltd | Gamma delta T cells and uses thereof |
| CN107075480A (zh) | 2014-07-09 | 2017-08-18 | Tc生物制药有限公司 | γδT细胞及其用途 |
| IL297773B2 (en) | 2014-11-17 | 2024-07-01 | Adicet Bio Inc | Engineered gamma delta t-cells |
| GB201507368D0 (en) * | 2015-04-30 | 2015-06-17 | Ucl Business Plc | Cell |
| CN105158466B (zh) * | 2015-05-05 | 2017-12-22 | 中国科学院广州生物医药与健康研究院 | 一种检测抗cd19的嵌合抗原受体t细胞对白血病细胞抑制作用的方法 |
-
2015
- 2015-04-15 GB GBGB1506423.1A patent/GB201506423D0/en not_active Ceased
-
2016
- 2016-04-14 CN CN201680034862.3A patent/CN107810267B/zh active Active
- 2016-04-14 US US15/566,324 patent/US10881688B2/en active Active
- 2016-04-14 AU AU2016250211A patent/AU2016250211B2/en active Active
- 2016-04-14 SG SG11201708401WA patent/SG11201708401WA/en unknown
- 2016-04-14 KR KR1020177032986A patent/KR20180012754A/ko not_active Ceased
- 2016-04-14 WO PCT/GB2016/051050 patent/WO2016166544A1/en not_active Ceased
- 2016-04-14 EP EP16721208.3A patent/EP3283620B1/en active Active
- 2016-04-14 CN CN202210369545.4A patent/CN114717194A/zh active Pending
- 2016-04-14 ES ES16721208T patent/ES2993441T3/es active Active
- 2016-04-14 CA CA2982523A patent/CA2982523A1/en active Pending
- 2016-04-14 BR BR112017022249A patent/BR112017022249A2/pt not_active Application Discontinuation
- 2016-04-14 EA EA201792041A patent/EA201792041A1/ru unknown
- 2016-04-14 JP JP2017554035A patent/JP6995624B2/ja active Active
-
2017
- 2017-10-12 ZA ZA2017/06922A patent/ZA201706922B/en unknown
- 2017-10-15 IL IL255011A patent/IL255011B/en unknown
-
2020
- 2020-11-19 US US16/953,068 patent/US20210252055A1/en not_active Abandoned
-
2021
- 2021-12-15 JP JP2021203173A patent/JP2022046549A/ja not_active Ceased
-
2022
- 2022-05-30 AU AU2022203664A patent/AU2022203664A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2018512161A5 (https=) | ||
| Wang et al. | Breakthrough of solid tumor treatment: CAR-NK immunotherapy | |
| Bassani et al. | Natural killer cells as key players of tumor progression and angiogenesis: old and novel tools to divert their pro-tumor activities into potent anti-tumor effects | |
| Vitale et al. | An historical overview: the discovery of how NK cells can kill enemies, recruit defense troops, and more | |
| JP6899333B2 (ja) | 汎用キラーｔ細胞 | |
| JP6422134B2 (ja) | キメラ抗原受容体 | |
| CN107249602B (zh) | 靶向血液恶性肿瘤之嵌合抗原受体（car）、其组合物及使用方法 | |
| De Bousser et al. | T cell engaging immunotherapies, highlighting chimeric antigen receptor (CAR) T cell therapy | |
| WO2018098365A3 (en) | Compositions and methods for tcr reprogramming using fusion proteins | |
| TW201920250A (zh) | 用於以基因方式修飾且擴展淋巴球以及調節其活性之方法及組合物 | |
| JP2016519933A5 (https=) | ||
| IL292650A (en) | Chimeric antigen receptor T cells target il13ra2 | |
| JP2018512161A (ja) | 修正ガンマデルタｔ細胞およびその使用 | |
| Kleinlützum et al. | Enhancing the oncolytic activity of CD133-targeted measles virus: receptor extension or chimerism with vesicular stomatitis virus are most effective | |
| JP6942466B2 (ja) | 抗原特異的ｔ細胞受容体遺伝子を有する多能性幹細胞の製造方法 | |
| US20150275209A1 (en) | Compositions and methods for enhancing cancer immunotherapy | |
| CN107227299A (zh) | Anti MUC1 CAR‑T细胞及其制备方法和应用 | |
| US20230310548A1 (en) | APPLICATION OF IFN-y IN PREPARING ANTI-TUMOR ADJUVANT DRUG | |
| CN113166224A (zh) | 用于治疗ebv相关性癌症的抗lmp2 tcr-t细胞疗法 | |
| JP6777841B2 (ja) | 細胞傷害性ｔ細胞の作製方法 | |
| CN107254447A (zh) | Anti AFP CAR‑T细胞及其制备方法和应用 | |
| Rafii et al. | Advancing CAR T-cell therapy in solid tumors: current landscape and future directions | |
| JP2022023136A5 (https=) | ||
| Bhattacharya et al. | Heterologous Prime-Boost with Immunologically Orthogonal Protein Nanoparticles for Peptide Immunofocusing | |
| Chen et al. | Viral‐Directed Augmentation of Kupffer Cell Cross‐Presentation Provokes Antitumor Immunity Against Liver Metastasis |